Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Asklepios Biopharmaceutical, Inc.
Sponsor:
Information provided by (Responsible Party):
Asklepios Biopharmaceutical, Inc.
ClinicalTrials.gov Identifier:
NCT01687608
First received: August 27, 2012
Last updated: October 9, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2029
  Estimated Primary Completion Date: November 2019 (Final data collection date for primary outcome measure)